Has John Wallbillich, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,093 in general payments to John Wallbillich, MD across 81 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Wallbillich, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Wallbillich, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Wallbillich, MD

Gynecologic Oncology · Augusta, GANPI 1396094744

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.8%), consulting fees and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Seagen Inc. at 47.9% of the total. Reporting peaked in 2021 at $2,193 and has fallen 85.4% since, to $321 in 2025.

$4,093in general payments, 2019–2025

Across 81 payments — averaging $50.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Seagen Inc.$2K
AstraZeneca$746
GSK$324
Merck$245
Myriad Genetic Laboratories, Inc.$143
Karyopharm Therapeutics Inc.$140
plus $535 from 11 others

$276,865in research payments, 2019–2025

Across 21 payments — averaging $13,184 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$255K
EMD Serono, Inc.$22K

What the payments were for

Consulting fees$1,92547%
Food & beverage$2,07951%
Education$892%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Seagen Inc.	3	$1,960
AstraZeneca	21	$746
GSK	21	$324
Merck	9	$245
Myriad Genetic Laboratories, Inc.	2	$143
Karyopharm Therapeutics Inc.	2	$140
Amniox Medical, Inc.	1	$107
Clovis Oncology, Inc.	6	$98
AbbVie	4	$84
Pfizer	2	$55
Caris MPI, Inc.	2	$53
EMD Serono, Inc.	2	$29
Daiichi Sankyo Inc.	2	$27
Tesaro, Inc.	1	$24
Eisai Inc.	1	$22
Astellas Pharma US Inc	1	$21
Novartis	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,093 in reported general payments places this provider in the 55th percentile of 49 gynecologic oncology providers in Georgia.

See all gynecologic oncology providers in Georgia →

Medicare billing

Part B allowed, 2024

$25,062

Medicare patients

Services billed

209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Augusta

Sharad GhamandeAugusta$214K
Robert HigginsAugusta$1K
Julia DonovanAugusta$283
James BurkeSavannah$276K
Benedict BenignoAtlanta$273K
Ruchi GargNewnan$125K
Adam PyrzakAtlanta$116K
Gerald FeuerAtlanta$102K
Margarett EllisonMoultrie$81K
Vijaya GalicGainesville$35K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →